10x Genomics, Inc. (BMV:TXG)

Mexico flag Mexico · Delayed Price · Currency is MXN
363.00
0.00 (0.00%)
At close: Jan 9, 2026
-17.50%
Market Cap49.09B
Revenue (ttm)11.77B
Net Income (ttm)-1.40B
Shares Outn/a
EPS (ttm)-11.35
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume94
Average Volume710
Open363.00
Previous Closen/a
Day's Range363.00 - 363.00
52-Week Range150.00 - 363.00
Betan/a
RSI27.78
Earnings DateFeb 13, 2026

About 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as ... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2012
Employees 1,306
Stock Exchange Mexican Stock Exchange
Ticker Symbol TXG
Full Company Profile

Financial Performance

In 2024, 10x Genomics's revenue was $610.79 million, a decrease of -1.28% compared to the previous year's $618.73 million. Losses were -$182.63 million, -28.41% less than in 2023.

Financial numbers in USD Financial Statements